Atsisiųsti - Medpraktika.lt

26
Coghill RC, McHaffie JG, Yen YF. Neural
correlates of interindividual differences in
the subjective experience of pain. Proc Natl
Acad Sci USA 2003;100:8538–42.
Cox JJ, Reimann F, Nicholas AK et al. An
SCN9A channelopathy causes congenital
inability to experience pain. Nature
2006;444:894–8.
Devor M. Neuropathic pain: what do we do
with all these theories? Acta Anaesthesiol
Scand 2001;45:1121–7.
Drenth JP, Waxman SG. Mutations in
sodium-channel gene SCn9a cause a
spectrum of human genetic pain disorders.
J Clin Invest 2007;117:3603–9.
Fields RD. New culprits in chronic pain.
Sci Am 2009;301:50–7.
Hutchinson MR, Coats BD, Lewis SS et al.
Proinflammatory cytokines oppose opioidinduced
acute and chronic analgesia. Brain
Behav Immun 2008;22:1178–89.
Melzack R, Wall PD. Pain mechanisms: a
new theory. Science 1965;150:971–9.
Milligan ED, Watkins LR. Pathological and
protective roles of glia in chronic pain. Nat
Rev Neurosci 2009;10:23–36.
Mogil JS. The genetic mediation of
individual differences in sensitivity to pain
and its inhibition. Proc Natl Acad Sci USA
1999;96:7744–51.
Mogil JS, McCarson KE. Identifying pain
genes: bottom-up and top-down
approaches. J Pain 2000;1:66–80.
National Pain Strategy. National Pain
Summit of Australia. www.painsummit.org.
au.
Siddall PJ, Cousins MJ. Persistent pain as a
disease entity: implications for clinical
management. Anesth Analg 2004;99:510–
20.
Siddall PJ, Cousins MJ. In: Cousins et al.,
2009 (žr. skyrelį „Naudingos nuorodos“).
Wrigley PJ, Press SR, Gustin SM et al.
Neuropathic pain and primary
somatosensory cortex reorganization
following spinal cord injury. Pain
2009;141:52–9.